Clinical efficacy of minimally invasive transforaminal lumbar interbody fusion and endoscopic lumbar interbody fusion in the treatment of lumbar degenerative diseases
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 5
Abstract
<b>Objective</b> To compare the safety and clinical efficacy of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) and endoscopic lumbar interbody fusion (Endo-LIF) for lumbar degenerative diseases. <b>Methods</b> A retrospective analysis was conducted on the data of 115 patients diagnosed with lumbar degenerative disease at Ningguo People's Hospital and Hangzhou First People's Hospital from January 2019 to July 2021, including 54 cases in the MIS-TLIF group and 61 cases in the Endo-LIF group. The clinical outcomes were compared before operation, and at 1 week, 1 month, 3 months and 1-year post-operation, including visual analogue scale (VAS), Oswestry disability index scores (ODI) and modified MacNab criteria. <b>Results</b> The surgical time in the Endo-LIF group was longer than that in the MIS-TLIF group ［(155.61±8.50) min vs (128.00±8.40) min］; however, the surgical bleeding volume ［(60.39±5.54) mL vs (129.39±8.59) mL］ and hospital stay ［(3.91±0.74) d vs (4.96±1.57) d］ in the Endo-LIF group were lower than those in the MIS-TLIF group, and the differences were statistically significant (P＜0.05). The VAS score of low back pain and ODI score in the two groups at each time point after operation were significantly lower than those before operation (P＜0.05). At 3 month, 1-year post-operation, the VAS score of the Endo-LIF group was lower than that of the MIS-TLIF group(P＜0.05). The 1-year post-operation MacNab efficacy evaluation showed no statistically significant difference in the excellent and good rates between the MIS-TLIF group and the Endo-LIF group (96.3% vs 96.7%, χ2=0.149, P＞0.05). <b>Conclusion</b> There was no significant difference in mediumshort term surgical outcomes between MIS-TLIF and Endo-LIF. Endo-LIF group has less damage to surrounding tissues, less intraoperative blood loss, and less low-back pain, which is more conducive to the recovery of patients in the long run. However, the indications of Endo-LIF are relatively limited, and the learning curve of Endo-LIF is deep, surgeons need to select indications strictly.
Authors and Affiliations
LIU Shukun*, CHEN Hao, DING Yi, WANG Xuepeng, ZHU Liulong
Keywords
Related Articles
- EP ID EP736329
- DOI 10.13429/j.cnki.cjcr.2024.05.009
- Views 86
- Downloads 0
Research progress of DEAD-box polypeptide 5 in breast cancer
Breast cancer, as a malignant tumor threatening the survival of women in China, its incidence rate is increasing year by year and showing a younger trend, control of cancer cell proliferation, invasion, metastasis is the...
Protective effect of esketamine on hepatic ischemia-reperfusion injury
Esketamine, as a perioperative sedative and analgesic drug, has been widely used in Europe and America. However, the protective effect of esketamine on the liver during the perioperative period is still in the applicated...
Efficacy and immunological effects of neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer
Objective To investigate the efficacy of neoadjuvant chemotherapy with gemcitabine and cisplatin (GC) in patients with muscle-invasive bladder cancer (MIBC), and its impact on immune function. Methods A retrospective a...
Analysis of risk factors for death in patients with sepsis
Objective To construct a death risk prediction model of sepsis, in order to provide reference for improving the early warning of death risk and improving the outcome of sepsis patients. Methods The data of 286 sepsis p...
Prognostic value of electrocardiogram in acute pulmonary embolism
Acute pulmonary embolism is a common acute cardiovascular disease in clinical practice. It can lead to respiratory and circulatory failure, with a poor prognosis for patients, and is one of the common causes of death in...